These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8803916)

  • 1. Retinopathy and antimalarial drugs--the British experience.
    Spalton DJ
    Lupus; 1996 Jun; 5 Suppl 1():S70-2. PubMed ID: 8803916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmologic considerations in using antimalarials in the United States.
    Rynes RI
    Lupus; 1996 Jun; 5 Suppl 1():S73-4. PubMed ID: 8803917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is new in recommendations on ophthalmological screening in patients treated with chloroquine and hydroxychloroquine? Update and literature review.
    Wiacek MP; Bobrowska-Snarska D; Lubiński W; Brzosko M; Modrzejewska M
    Niger J Clin Pract; 2017 Aug; 20(8):919-923. PubMed ID: 28891533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and prevention of maculopathy associated with antimalarial agents.
    Easterbrook M
    Int Ophthalmol Clin; 1999; 39(2):49-57. PubMed ID: 10343924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update on recommendations for screening for hydroxychloroquine retinopathy].
    Couturier A; Giocanti-Aurégan A; Dupas B; Girmens JF; Le Mer Y; Massamba N; Barreau E; Audo I;
    J Fr Ophtalmol; 2017 Nov; 40(9):793-800. PubMed ID: 29054477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography.
    Cabral RTS; Klumb EM; Couto MINN; Carneiro S
    Arq Bras Oftalmol; 2019; 82(1):12-17. PubMed ID: 30403262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular toxicity of hydroxychloroquine.
    Yam JC; Kwok AK
    Hong Kong Med J; 2006 Aug; 12(4):294-304. PubMed ID: 16912357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose relationships in patients with early chloroquine retinopathy.
    Easterbrook M
    J Rheumatol; 1987 Jun; 14(3):472-5. PubMed ID: 3625628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of macular changes with multifocal ERG in patients on antimalarial drug therapy.
    Nebbioso M; Grenga R; Karavitis P
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):249-58. PubMed ID: 19348599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine-induced retinal toxicity.
    Rivett K
    S Afr Med J; 2004 Jan; 94(1):41. PubMed ID: 14971230
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
    Kobak S; Deveci H
    Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe chloroquine- and hydroxychloroquine-induced retinopathy].
    Ingster-Moati I; Bui Quoc E; Crochet M; Orssaud C; Dufier JL; Roche O
    J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
    Ruiz RS; Saatci OA
    Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
    Wei LC; Chen SN; Ho CL; Kuo YH; Ho JD
    Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chloroquine retinopathy: avoidable by individualized daily dosing].
    Ochsendorf FR; Runne U; Goerz G; Zrenner E
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1895-8. PubMed ID: 8287780
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular effects and safety of antimalarial agents.
    Easterbrook M
    Am J Med; 1988 Oct; 85(4A):23-9. PubMed ID: 3177429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal toxicity induced by antimalarial drugs: literature review and case report.
    Garza-Leon M; Flores-Alvarado DE; Muñoz-Bravo JM
    Medwave; 2016 Jun; 16(5):e6471. PubMed ID: 27391903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term course of chloroquine retinopathy after cessation of medication.
    Brinkley JR; Dubois EL; Ryan SJ
    Am J Ophthalmol; 1979 Jul; 88(1):1-11. PubMed ID: 463998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimalarial drug retinopathy].
    Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
    Rev Med Interne; 2018 May; 39(5):364-368. PubMed ID: 29496271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.